CloudMe and Globell launch a secure joint European Cloud for the German speaking market
07 juin 2017 08h58 HE
|
Xcerion AB
Linköping/Tegelen, EU, June 07, 2017 (GLOBE NEWSWIRE) -- CloudMe, Europe’s leading provider of cloud sync and storage, with over 1.5 million subscribers, and Globell, the software distributor...
Kanguru: Why Non-EU Organizations Can’t Afford To Ignore GDPR
31 mai 2017 07h00 HE
|
Kanguru Solutions
MILLIS, Mass., May 31, 2017 (GLOBE NEWSWIRE) -- One of the biggest changes in data security regulations is coming out of the European Union that will have a significant impact on organizations...
bioAffinity Technologies Announces Award of European Union Patent
03 mai 2017 14h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, May 03, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the European Patent Office (EPO) has issued a patent that protects the Company’s proprietary CyPath®...
Institutional Investors Facing Difficult Challenge as Passive Investing, Unbundling, and Cost Pressures Threaten Their Very Existence According To TABB Group’s Latest Research - US Institutional Equity Trading 2017: In the Eye of the Storm
17 avr. 2017 10h30 HE
|
TABB Group
NEW YORK and LONDON, April 17, 2017 (GLOBE NEWSWIRE) -- The reallocation of assets from active, fundamentally-based investment strategies to passive/ETF index-based products has the industry on...
XOMA Reports Second Quarter 2016 Achievements and Financial Results
03 août 2016 16h01 HE
|
XOMA Corporation
BERKELEY, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced recent achievements and...
XOMA Receives Orphan Drug Designation in the European Union for XOMA 358 for Treatment of Congenital Hyperinsulinism
20 juil. 2016 09h00 HE
|
XOMA Corporation
XOMA 358 previously secured Orphan Drug Designation from the FDA for the treatment of Congenital Hyperinsulinism (CHI)Phase 2 clinical studies currently enrolling patients with CHI in the United...
Apigee Announces New Open Banking Solution for PSD2
19 mai 2016 03h00 HE
|
Apigee
LONDON, May 19, 2016 (GLOBE NEWSWIRE) -- OPEN BANKING & PSD2 SUMMIT — Apigee® (NASDAQ:APIC), developer of a leading API platform, today announced Apigee Open Banking APIx, a new software...
WebMoney Gets a European License and is Expanding Its Presence in the European Union
17 nov. 2015 05h00 HE
|
WebMoney
LONDON, Nov. 17, 2015 (GLOBE NEWSWIRE) -- The FCA (Financial Conduct Authority) license granted to WebMoney Europe Ltd with head offices in Cambridge, United Kingdom has secured the company's status...
Hemispherx Biopharma Europe N.V./S.A.: Orphan Medicine Designation and European Medicines Agency Public Opinion Summary Published by EMA Regarding Ampligen/Rintatolimod for Ebola Virus Disease (EVD)
26 mai 2015 12h46 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 26, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announces that the European Medicines Agency (EMA) has published on May 22,...
HSH.com Weekly Mortgage Rates Radar: Fixed Mortgage Rates Jump Back to December Levels
13 mai 2015 05h10 HE
|
QuinStreet
FOSTER CITY, Calif., May 13, 2015 (GLOBE NEWSWIRE) -- Rates on the most popular types of mortgages climbed again this week, according to HSH.com's Weekly Mortgage Rates Radar. The average rate for...